Evidence map›Paper›PMID 35147866›Full record

ReviewCurrent psychiatry reports2022

Rethinking the Approach to Preclinical Models of Anorexia Nervosa.

Marie François, Lori M Zeltser

Abstract readReview
In one paragraph

Review in Current psychiatry reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. A small-molecule degrader of TET3 as treatment for anorexia nervosa in an animal model.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Marie FrançoisDivision of Molecular Genetics, Naomi Berrie Diabetes Center, Columbia University Irving Medical Center, New York, USA.
Lori M ZeltserDivision of Molecular Genetics, Naomi Berrie Diabetes Center, Columbia University Irving Medical Center, New York, USA. lz146@cumc.columbia.edu.

Funding

Functional mapping of arginine vasopressin receptor 1A circuits that promote anorexic behaviorR01MH113353 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ZELTSER, LORI M · 2018 to 2022
$2.3M
NIMH NIH HHS R01 MH113353
6 · The paper itself

Abstract

purpose of reviewThe goal of this review is to describe how emerging technological developments in pre-clinical animal research can be harnessed to accelerate research in anorexia nervosa (AN). RECENT

findingsThe activity-based anorexia (ABA) paradigm, the best characterized animal model of AN, combines restricted feeding, excessive exercise, and weight loss. A growing body of evidence supports the idea that pathophysiological weight loss in this model is due to cognitive inflexibility, a clinical feature of AN. Targeted manipulations that recapitulate brain changes reported in AN - hyperdopaminergia or hyperactivity of cortical inputs to the nucleus accumbens - exacerbate weight loss in the ABA paradigm, providing the first evidence of causality. The power of preclinical research lies in the ability to assess the consequences of targeted manipulations of neuronal circuits that have been implicated in clinical research. Additional paradigms are needed to capture other features of AN that are not seen in ABA.

Indexed as

Anorexia NervosaAnimalsAnorexiaDisease Models, AnimalHumansNeuronsWeight LossActivity-based anorexiaAnimal modelsAnorexia nervosaCognitive inflexibilityNeural circuitsPerseverative behavior

Identifiers

PMID35147866
PMCPMC8898221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.